AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin T at the Point of Care

COPENHAGEN, September 20, 2010 – Radiometer has added the cardiac marker Troponin T* (TnT) to its AQT90
FLEX immunoassay analyzer for the use at the point of care. According to
Radiometer President Peter Kurstein, the new marker enables healthcare
professionals to improve processes in emergency rooms and labs, ultimately
helping hospitals improve patient care and reduce costs.

[...]

24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added to Glimepiride in Adults With Type 2 Diabetes Mellitus

STOCKHOLM, September 20, 2010 – Bristol-Myers Squibb Company (NYSE: BMY)(www.bms.com) and
AstraZeneca (NYSE: AZN)(www.astrazeneca-us.com)
today announced results from a randomized, double blind Phase 3 clinical
study, which demonstrated that the addition of the investigational drug
dapagliflozin to existing glimepiride (sulphonylurea) therapy produced
significant reductions in glycosylated hemoglobin levels (HbA1c) in adult
patients with type 2 diabetes compared to glimepiride [...]

Sanofi-aventis: Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients With Type 2 Diabetes

Phase III Study Results Also Demonstrated the Therapy had Acceptable Safety Profile

PARIS, September 20, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
the first Phase III results of the GetGoal clinical trial program assessing
the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist,
as monotherapy in patients with type 2 diabetes. These results [...]

Three Million Give ‘Thumbs Up’ to Saving Children’s Lives

Claire Danes to unveil unique visual petition in Grand Central Terminal on Monday 20th September, 1300 hrs

NEW YORK, September 20, 2010 – Emmy award-winning actress Claire Danes will join millions of people
who've added their thumbprints to an innovative and unique global petition at
Grand Central Terminal, lead by global humanitarian organisation Save the
Children.
[...]

CareFusion Launches Next-Generation Clinical Diagnostics Software for Jaeger(TM) and SensorMedics(R) Product Lines

HOCHBERG, Germany, September 20, 2010 – CareFusion (NYSE: CFN), a leading, global medical device company, today
announced the commercial release of SentrySuite(TM), the next-generation
clinical diagnostics software for the Jaeger(TM) and SensorMedics(R)
Pulmonary Diagnostics and CardioPulmonary Diagnostics instruments.

SentrySuite is an innovative set of software applications to assist with
clinically intelligent diagnostics to improve the [...]

Boston Scientific Receives Exclusive Expanded Indication for its CRT-Ds

FDA Approval is Based on Results From the Company's Landmark MADIT-CRT Trial

NATICK, Massachusetts, September 20, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that
the U.S. Food and Drug Administration (FDA) has approved an expanded
indication for its cardiac resynchronization therapy defibrillators (CRT-Ds),
including the COGNIS(R) CRT-D. The exclusive expanded indication is effective
immediately and makes Boston [...]

Sanofi-aventis: Adding Lantus(R) to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients With Type 2 Diabetes

Findings Presented at European Association for the Study of Diabetes (EASD) 46th Annual Meeting

PARIS, September 20, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
results of two studies presented at the European Association for the Study of
Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden. The first pooled
analysis using patient-level data from randomized clinical [...]

Parents Putting Their Children at Risk due to Poor Diagnosis of Serious Illnesses

Millions of Parents are not Confident About Taking Their Child's Temperature

LONDON, September 20, 2010 – Three quarters of parents aren't confident about diagnosing illness in
their own children, according to results of a new survey released today.
Worryingly, nearly half of the parents surveyed aren't aware of the
normal body temperature range of [...]

Daxas(R) (roflumilast) Data Analysis Shows Reduction in Harmful Lung Attacks

ZURICH, September 20, 2010 -

– Global Survey Published Today Shows Long-Term Impact of Exacerbations
Seriously Underestimated[1]

– More Than Three Quarters of Patients Surveyed Suffer From
Exacerbations[1]

– New Data Analysis Released at ERS [...]

Heads of State, Leading CEOs, Entrepreneurs and World-Renowned Artists Gather in New York City From September 22-23 for the 2010 Blouin Creative Leadership Summit

NEW YORK, September 20, 2010 – The Louise Blouin Foundation (LBF) is pleased to announce the fifth
annual Blouin Creative Leadership Summit (BCLS), a forum in partnership with
the United Nations Office of Partnerships that engages in dialogue and
exchanges best practices to successfully confront the challenges and
opportunities brought about by globalization over the coming decade.

[...]

Nonin Medical to Introduce New Innovations at ERS 2010 Annual Congress

Next-Generation Wrist-Worn Pulse Oximeter, Disposable Sensors, Pulse Oximetry Clinical Guidebook, European Center Unveiled at Booth #C.100

MINNEAPOLIS, September 20, 2010 – Nonin Medical, Inc., a leading innovator of noninvasive physiological
monitoring solutions, today introduced new pulse oximetry products, a new
clinical guidebook and a new European sales, distribution and customer
service center at the European Respiratory Society (ERS) [...]

AMT’s EGM Passes All Resolutions and Strengthens Supervisory Board With Joseph Feczko, Steven Holtzman and Francois Meyer

AMSTERDAM, September 20, 2010 – Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT), a
leader in the field of human gene therapy, announced today that its
Extraordinary General Meeting of Shareholders passed all resolutions set out
in the Notice of the Meeting dated August 9, 2010, including an increase of
the authorized capital and the appointments of Dr. [...]

Kinetic Systems Appoints Peter M. Maris President & Chief Executive Officer

DURHAM, North Carolina, September 20, 2010 – Kinetic Systems, Inc., a leading global provider of process and
mechanical solutions to electronics, biopharmaceutical and general industry
clients, announced today the appointment of Peter M. Maris as President and
Chief Executive Officer as well as to its Board of Directors. He will also
continue to oversee the International Operations division.

[...]

Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting

Awards fund early career investigators' research to advance understanding and potential treatments of alpha1-antitrypsin deficiency

BARCELONA, Spain, September 20, 2010 – Talecris Biotherapeutics GmbH announced yesterday the recipients of the
2010 European alpha1-antitrypsin Laurell's Training Awards (eALTA). The
annual awards, sponsored by Talecris, provide two fellowships of euro 50,000
to young investigators whose research aims to enhance the [...]

NewBridge Pharmaceuticals Completes US$12 Million First Close of Series B Financing, Announces Senior Executive Appointments

DUBAI, United Arab Emirates, September 20, 2010 – NewBridge Pharmaceuticals FZ-LLC of Dubai, UAE announced today that
Joseph W. Henein has been appointed President and Chief Executive Officer and
a member of the company's Board of Directors. Mr. Henein is a senior
executive who joins NewBridge after a career extending over 29 years in
multinational pharmaceutical corporations, holding [...]